 |
Generic Name: Exemestane
Brand Name(s): Aromasin®
IUPAC: (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
FDA Approval: yes
Manufacturer Link
|
Usage: Exemestane (Aromasin®) binds irreversibly (permanently) to the aromatase
enzyme. This stops it from being able to make
estrogen and prevents the growth of estrogen dependent cancer.
Mechanism: Exemestane (Aromasin®) binds irreversibly (permanently) to the aromatase enzyme. This stops aromatase from being able to make estrogen and prevents the growth of estrogen dependent cancer.
Side Effects: Common side effects include: hot flashes, nausea, fatigue, eye disturbances, headaches dizziness, insomnia, depression, hypertension, joint pain, limb pains, back pains and osteoarthritis. There are no studies for aromasin in pregnant women yet. It is recommended only for postmenopausal women. If exposed to aromasin while pregnant, patients should contact a physician to assess the potential hazard to the fetus and possible risk of pregnancy loss.
Contraindications: AROMASIN Tablets are not advised for use in patients with a known hypersensitivity (severe allergic reaction) to the drug or to any of its ingredients.